Hhcefi 100mg Dry Syrup 30 ml

babies: it is safe to use this medicine in babies. please consult your doctor before using this medicine. lactating mothers: this medicine should be used with caution during breastfeeding.
please consult your doctor before using this medicine during lactation. pregnancy: this medicine should be used with caution during pregnancy.
seek the doctor's advice before using this medicine. alcohol: avoid consumption of alcohol while taking this medicine. please consult your doctor before using this medicine. driving: this medicine may cause feeling confused and alters your ability to drive.
do not drive if you experience these symptoms. kidney: this medicine should be used with caution in patients with kidney disease.
dose adjustment is required. seek a doctor's advice before taking this medicine. liver: this medicine should be used with caution in patients with liver diseases.
studies have shown that dose adjustment is required in these patients. seek a doctor's advice before using this medicine..

dizziness abdominal pain diarrhea taste changes chest pain sore throat.

hhcefi belongs to a class of third-generation cephalosporins used in the treatment of bacterial infections. it kills the bacteria causing infection by preventing the protective covering of the cell wall required for the bacteria to survive..

if you miss a dose, take it as soon as possible. if it is near the time of the next dose, then skip the missed dose.
take the prescribed dose on your regular time daily. don't double the dose to catch up with the missed dose..

• take this medicine as prescribed by your doctor • do not stop taking this medicine without consulting your doctor • read the label for directions carefully before using this medicine • shake well the bottle before using this medicine • if you experience taste change, diarrhoea, dizziness, and abdominal pain for a longer duration, inform your doctor.

• hhcefi + amikacin: concurrent use may lead to an increase in the risk of kidney damage • hhcefi + dicumarol: concurrent use may lead to an increase in the risk of bleeding • hhcefi + furosemide: concurrent use may lead to an increase in the risk of kidney problems • hhcefi + gentamicin: concurrent use may lead to an increase in the risk of kidney damage • hhcefi + tobramycin: concurrent use may lead to an increase in the risk of kidney damage.